Japan Plaintiffs Agree To Settle Twin Suits Against AstraZeneca Drug
This article was originally published in PharmAsia News
Executive Summary
Japanese plaintiffs seeking damages in drug suits against the government and U.K.-based AstraZeneca agreed to settle of two suits as suggested by district court judges